CardioRisk Laboratories The Leader in Cardiovascular Health
CardioRisk offers a non-invasive diagnostic test (CIMT) which detects atherosclerotic disease responsible for the majority of Heart Attacks and Strokes. In a 10-year, 100,000 person-year study, this test caught 98.6% of the events BEFORE they occurred. The test measures atherosclerotic plaque and inflammation.
Unique in its ability to visualize disease at its earliest formation, to measure inflammation and to characterize the nature of identified plaques as either soft and vulnerable to rupture, or echogenic and stable, CIMT empowers patients and providers to treat the disease, not just the risk of disease. CIMT scanning is a non‐invasive ultrasound procedure, which takes only 15 minutes, and has no known associated risks, (no radiation, no needle sticks, no disrobing required). The test measures the thickness (amount of inflammation) of the inner most layers of the carotid artery and detects atherosclerotic plaque responsible for the majority of heart attacks and strokes.
Take this opportunity to get a CIMT test at the Health Pavilion. There are a limited number of appts available so make sure to book early at www.cardiorisk.us/hinman2022
Brands: CardioRisk CIMT
ABI
AAA